FEDERAL COURT OF AUSTRALIA
Quality Medical Innovations Pty Ltd v Keogh [2021] FCA 154
File number: NSD 1171 of 2020 Judgment of: MARKOVIC J Date of judgment: 2 March 2021 Catchwords: CORPORATIONS – directors’ duties – where first defendant is a director of the first plaintiff and second defendant – where second defendant produces and sells products in a similar market to the first plaintiff – application for injunctive relief under s 1324 of the Corporations Act 2001 (Cth) (Corporations Act) – alleged contraventions of ss 181-183 of the Corporations Act – whether the evidence establishes a sufficiently seriously arguable case of those contraventions – whether balance of convenience favours the grant of relief sought – application dismissed Legislation: Corporations Act 2001 (Cth) ss 181, 182, 183, 1324 Cases cited: Armstrong World Industries (Australia) Pty Limited v Parma (2014) 101 ACSR 150; [2014] FCA 743
Australian Careers Institute Pty Ltd v Australian Institute of Fitness Pty Ltd (2016) 340 ALR 580; [2016] NSWCA 347
Australian Securities and Investments Commission v Adler (2002) 168 FLR 253
Australian Securities and Investments Commission v Mauer-Swisse Securities Limited (2002) 42 ACSR 605 at 613-614; [2002] NSWSC 741
Beecham Group Ltd v Bristol Laboratories Pty Ltd (1968) 118 CLR 618
Fitzpatrick v Cheal (2012) 264 FLR 313; [2012] NSWSC 261
In the matter of Ikon Group Limited (2015) 107 ACSR 146; [2015] NSWSC 980
Links Golf Tasmania Pty Ltd v Sattler (2012) 213 FCR 1
Division: General Division Registry: New South Wales National Practice Area: Commercial and Corporations Sub-area: Corporations and Corporate Insolvency Number of paragraphs: 96 Date of hearing: 16 February 2021 Counsel for the Plaintiffs: Mr M Maconachie Solicitor for the Plaintiffs: Donovan Oates Hannaford Counsel for the Defendants: Mr J Conde Solicitor for the Defendants: Thynne + Macartney ORDERS
NSD 1171 of 2020 BETWEEN: QUALITY MEDICAL INNOVATIONS PTY LTD ACN 101 586 476
First Plaintiff
MR KIM LEONARD GAUL
Second Plaintiff
AND: MR MICHAEL PHILLIP KEOGH
First Defendant
MAJAC MEDICAL PRODUCTS PTY LIMITED ACN 086 942 421
Second Defendant
ORDER MADE BY:
MARKOVIC J
DATE OF ORDER:
2 MARCH 2021
THE COURT ORDERS THAT:
1.Paragraphs 2 to 6 of the plaintiffs’ interlocutory application filed on 4 December 2020 be dismissed.
2.Each party pay their own costs of this application.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
REASONS FOR JUDGMENT
MARKOVIC J:
On 27 October 2020, Kim Leonard Gaul as plaintiff commenced this proceeding against Quality Medical Innovations Pty Limited (QMI), Michael Phillip Keogh and Majac Medical Products Pty Limited (Majac) as first, second and third defendants respectively. Dr Gaul and Mr Keogh are both directors of and equal shareholders in QMI. Mr Keogh is the sole director of and shareholder in Majac.
At the time of commencement of the proceeding…
Keep reading for free
Create a free CaseChat account to read Quality Medical Innovations Pty Ltd v Keogh and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2021] FCA 154
- Decision Date
CaseChat Overview and Summary
Orders
Orders of the court
1. Paragraphs 2 to 6 of the plaintiffs’ interlocutory application filed on 4 December 2020 be dismissed.
2. Each party pay their own costs of this application.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
At the time of commencement of the proceeding Dr Gaul sought relief under s 232 and s 233 of the Corporations Act 2001 (Cth) (Corporations Act) and orders requiring QMI to commence proceedings against Mr Keogh and Majac for, among other things, alleged breaches by Mr Keogh of his director’s duties and passing off. On 4 December 2020, Dr Gaul filed an interlocutory process (IP) seeking leave to commence proceedings in the name of QMI against Mr Keogh and Majac in respect of causes of action pleaded in a draft statement of claim (which has been subsequently filed) and for interim injunctive relief pursuant to s 1324 of the Corporations Act. On 14 December 2020, orders were made by consent including an order granting Dr Gaul leave to join QMI as a plaintiff to the proceeding and otherwise dismissing Dr Gaul’s application for leave to commence a proceeding in the name of QMI as sought in para 1 of the IP. As a result, the parties to this proceeding now comprise QMI and Dr Gaul as first and second plaintiffs respectively and Mr Keogh and Majac as first and second defendants respectively. QMI and Dr Gaul press their application for interim injunctive relief included at paras 2 and 3 of the IP. They seek the following orders:2.An order that [Mr Keogh and Majac], by themselves, their employees, or agents, be restrained until further order from:(a)making representations in trade or commerce about or relating to any products of [QMI], or any brand or trademark associated with [QMI];(b)offering for sale, under any trading name, brand or trademark, any product created or derived from chemical formulae being the property of [QMI];(c)offering for sale, under any trading name, brand or trademark, any product created or derived from formulae for the products offered for sale by [QMI] under any of the trademarks set out in the schedule attached hereto in the column headed "QMI Trademark";(d)offering for sale any product under the trademarks or brands set out in the schedule attached hereto in the column headed "Majac mark".3. In the alternative to prayer 2, an order that until further order:(a)[Majac] pay all proceeds from the sale of any product sold under any of the brands set out in the schedule attached hereto in the column headed "Majac mark" into a bank account dedicated for that purpose (Escrow Account);(b)[Majac] be restrained from withdrawing any funds from the Escrow Account save for any account-keeping or other administrative fees relating to the maintenance of the Escrow Account;(c)[Majac] is to provide to the plaintiff a monthly statement for the Escrow Account;(d)[Majac] is to facilitate inspection of its books and records by qualified professionals engaged on behalf of the plaintiff for the purpose of confirming [Majac’s] compliance with these orders. In the course of the hearing of QMI and Dr Gaul’s application for the relief set out in the preceding paragraph, Mr Keogh proffered an undertaking (Undertaking) to the Court until determination or settlement of the proceeding or further order in the terms of para 2(a) of the IP which has been noted. The Undertaking is a complete answer to the claim for relief in para 2(a) of the IP.